ONG-COVID-19 also in pediatric patients. A pilot study asking if a comprehensive aftercare is necessary for children and young adults after a SARS-CoV-2 infectio
Recruiting
- Conditions
- U07.4U07.5
- Registration Number
- DRKS00024835
- Lead Sponsor
- Zentrum für Kinder und Jugendmedizin des Universitätsklinikums Essen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
SARS-CoV-2 infection (PCR positive nasale) or no history of infection
Exclusion Criteria
chronical illnesses, medication of immunsuppressiva
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Do we need a comprehensive aftercare also for pediatric patients after a SARS-CoV-2 infection?
- Secondary Outcome Measures
Name Time Method Do we need a cross-sectional study?
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie long-COVID symptoms in pediatric patients post-SARS-CoV-2 infection?
How does comprehensive aftercare for long-COVID in children compare to standard-of-care management strategies?
Are specific biomarkers associated with persistent SARS-CoV-2 infection effects in pediatric populations?
What adverse events are reported in long-COVID observational studies involving children and adolescents?
What therapeutic approaches are being explored for long-COVID in pediatric patients beyond DRKS00024835?